Boldenone, testosterone and 1,4‐androstadiene‐3,17‐dione determination in faeces from horses, untreated and after administration of androsta‐1,4‐diene‐3,17‐dione (boldione)

Faeces, which could be a potential alternative medium for doping control, have been used for the detection of 1,4‐androstadiene‐3,17‐dione administration to the horse. Semi‐quantitative analyses of 1,4‐androstadiene‐3,17‐dione, testosterone, 17 α ‐ and 17 β ‐boldenone have been conducted in pre‐ and post‐administration faeces, and in controls (untreated stallions, geldings and mares). Sample preparation comprised diethyl ether extraction, lipid removal, HPLC purification and derivatisation. 1,4‐Androstadiene‐3,17‐dione, testosterone, 17 α ‐ and 17 β ‐boldenone were analysed by GC‐EI/MS/MS. Quantitative limits of detection were 0.1 ng/g for 1,4‐androstadiene‐3,17‐dione, and 0.025 ng/g for testosterone, 17 α ‐ and 17 β ‐testosterone. In post‐administration samples from geldings and mares, peak levels of 1,4‐androstadiene‐3,17‐dione, 17 α ‐, 17 β ‐boldenone and testosterone were attained 24 h after administration. In untreated geldings and mares (in di‐ or anoestrus), 17 α ‐ and 17 β ‐boldenone and testosterone were not detected. Faeces from females in oestrus had detectable levels of boldenone isomers and testosterone. 1,4‐Androstadiene‐3,17‐dione was undetectable in faeces collected from untreated horses, but the presence of this androgen was recently reported in faeces from untreated swine and it would therefore be advisable to check for its possible presence in a larger number of individual faecal samples. Copyright © 2008 John Wiley & Sons, Ltd.